(LI) Klepierre - Ratings and Ratios
Shopping Centers, Retail Space, Mall Management
Dividends
| Dividend Yield | 5.58% |
| Yield on Cost 5y | 13.23% |
| Yield CAGR 5y | 16.63% |
| Payout Consistency | 94.0% |
| Payout Ratio | 44.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 16.4% |
| Value at Risk 5%th | 27.1% |
| Relative Tail Risk | 0.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.31 |
| Alpha | 21.34 |
| CAGR/Max DD | 1.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.487 |
| Beta | -0.041 |
| Beta Downside | 0.016 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.86% |
| Mean DD | 4.16% |
| Median DD | 4.07% |
Description: LI Klepierre January 06, 2026
Klepierre SA (ticker LI) is a French-headquartered REIT that exclusively operates large-scale shopping malls across continental Europe. As of 30 June 2025, the company’s assets were valued at €20.6 billion, spanning more than 10 countries and drawing roughly 700 million visitors per year. It is listed on Euronext Paris, belongs to the CAC Next 20 and EPRA Euro Zone Indexes, and is recognized in several sustainability indices (e.g., MSCI Europe ESG Leaders, FTSE4Good) and CDP’s “A List”.
Key operational metrics from recent filings show an average occupancy rate of 94 % and a net rental income growth of 5 % year-on-year in Q2 2025, while net debt remains at 4.2 × EBITDA, indicating moderate leverage. The sector’s performance is closely tied to consumer discretionary spending and tourism flows, both of which are sensitive to macro-economic factors such as inflation trends and real-interest-rate movements that affect disposable income and retail footfall.
For a deeper quantitative assessment of Klepierre’s valuation and risk profile, the ValueRay platform provides a concise dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (1.55b TTM) > 0 and > 6% of Revenue (6% = 170.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 1.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -51.39% (prev -91.32%; Δ 39.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.78b > Net Income 1.55b (YES >=105%, WARN >=100%) |
| Net Debt (7.58b) to EBITDA (1.77b) ratio: 4.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (286.8m) change vs 12m ago 0.15% (target <= -2.0% for YES) |
| Gross Margin 74.41% (prev 72.72%; Δ 1.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.53% (prev 9.16%; Δ 4.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 47.34 (EBITDA TTM 1.77b / Interest Expense TTM 36.8m) >= 6 (WARN >= 3) |
Altman Z'' 0.31
| (A) -0.07 = (Total Current Assets 1.52b - Total Current Liabilities 2.98b) / Total Assets 21.88b |
| (B) 0.03 = Retained Earnings (Balance) 617.6m / Total Assets 21.88b |
| (C) 0.08 = EBIT TTM 1.74b / Avg Total Assets 21.04b |
| (D) 0.09 = Book Value of Equity 1.02b / Total Liabilities 11.18b |
| Total Rating: 0.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.29
| 1. Piotroski 5.0pt |
| 2. FCF Yield 7.38% |
| 3. FCF Margin 44.39% |
| 4. Debt/Equity 0.99 |
| 5. Debt/Ebitda 4.28 |
| 6. ROIC - WACC (= 6.11)% |
| 7. RoE 18.59% |
| 8. Rev. Trend 30.54% |
| 9. EPS Trend 1.93% |
What is the price of LI shares?
Over the past week, the price has changed by -2.18%, over one month by +0.36%, over three months by +3.69% and over the past year by +25.17%.
Is LI a buy, sell or hold?
What are the forecasts/targets for the LI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.2 | 6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.6 | 25.2% |
LI Fundamental Data Overview January 06, 2026
Market Cap EUR = 9.54b (9.54b EUR * 1.0 EUR.EUR)
P/E Trailing = 8.1022
P/E Forward = 11.8906
P/S = 5.5114
P/B = 1.1027
P/EG = 9.6715
Beta = 0.952
Revenue TTM = 2.85b EUR
EBIT TTM = 1.74b EUR
EBITDA TTM = 1.77b EUR
Long Term Debt = 6.22b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.96b EUR (from shortTermDebt, last quarter)
Debt = 8.54b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.58b EUR (from netDebt column, last quarter)
Enterprise Value = 17.12b EUR (9.54b + Debt 8.54b - CCE 957.1m)
Interest Coverage Ratio = 47.34 (Ebit TTM 1.74b / Interest Expense TTM 36.8m)
FCF Yield = 7.38% (FCF TTM 1.26b / Enterprise Value 17.12b)
FCF Margin = 44.39% (FCF TTM 1.26b / Revenue TTM 2.85b)
Net Margin = 54.39% (Net Income TTM 1.55b / Revenue TTM 2.85b)
Gross Margin = 74.41% ((Revenue TTM 2.85b - Cost of Revenue TTM 728.3m) / Revenue TTM)
Gross Margin QoQ = 77.03% (prev 72.69%)
Tobins Q-Ratio = 0.78 (Enterprise Value 17.12b / Total Assets 21.88b)
Interest Expense / Debt = 0.43% (Interest Expense 36.8m / Debt 8.54b)
Taxrate = 12.53% (49.5m / 394.5m)
NOPAT = 1.52b (EBIT 1.74b * (1 - 12.53%))
Current Ratio = 0.51 (Total Current Assets 1.52b / Total Current Liabilities 2.98b)
Debt / Equity = 0.99 (Debt 8.54b / totalStockholderEquity, last quarter 8.65b)
Debt / EBITDA = 4.28 (Net Debt 7.58b / EBITDA 1.77b)
Debt / FCF = 6.00 (Net Debt 7.58b / FCF TTM 1.26b)
Total Stockholder Equity = 8.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.08% (Net Income 1.55b / Total Assets 21.88b)
RoE = 18.59% (Net Income TTM 1.55b / Total Stockholder Equity 8.33b)
RoCE = 11.97% (EBIT 1.74b / Capital Employed (Equity 8.33b + L.T.Debt 6.22b))
RoIC = 9.38% (NOPAT 1.52b / Invested Capital 16.24b)
WACC = 3.27% (E(9.54b)/V(18.07b) * Re(5.87%) + D(8.54b)/V(18.07b) * Rd(0.43%) * (1-Tc(0.13)))
Discount Rate = 5.87% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.09%
[DCF Debug] Terminal Value 80.07% ; FCFE base≈1.08b ; Y1≈1.23b ; Y5≈1.69b
Fair Price DCF = 102.3 (DCF Value 29.29b / Shares Outstanding 286.3m; 5y FCF grow 16.26% → 3.0% )
EPS Correlation: 1.93 | EPS CAGR: -42.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 30.54 | Revenue CAGR: -12.47% | SUE: 0.71 | # QB: 0
EPS next Year (2026-12-31): EPS=2.77 | Chg30d=-0.005 | Revisions Net=-1 | Growth EPS=+2.7% | Growth Revenue=+2.5%